Home > Research > Scientific Programmes: Biotechnology Programme > Monoclonal Antibodies Core Unit

Biotechnology Programme

Monoclonal Antibodies Core Unit

Head of Unit:  Giovanna Roncador

The development of monoclonal antibody (mAb) technology has led to the generation of large panels of highly specific reagents that have had a tremendous impact on basic and applied research over the last four decades. MAbs have become indispensable tools for many of the laboratory techniques that are used to answer essential questions in biomedical research. Their outstanding specificity makes them excellent tools for enabling researchers to better understand biological processes; particularly in the investigation of new approaches for the diagnosis, prevention and treatment of cancer.

The Monoclonal Antibodies Unit provides CNIO Research Groups with an à la carte generation of mAbs. We are highly specialised in the production of mouse and rat mAbs. The Unit also offers mAb production in gene-inactivated mice, mAb characterisation and validation, medium-scale mAb production, and a service of Mycoplasma testing for the cell culture facility.